MedPath

SANDOZ OSELTAMIVIR

SANDOZ OSELTAMIVIR

Approved
DIN Number

02504022

Drug Class

Human

Market Date

Oct 2, 2020

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02504022
AIG Number0139501001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AH02 OSELTAMIVIR
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification08:18.28
Health Canada Classification

ACTIVE INGREDIENTS (1)

OSELTAMIVIR (OSELTAMIVIR PHOSPHATE)Active
Strength: 75 MG
Monograph: OSELTAMIVIR (OSELTAMIVIR PHOSPHATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.